260 SUCCESSFUL THERAPY WITH PEGYLATED INTERFERON ALFA-2A AND RIBAVIRIN CAUSES A SUSTAINED DECREASE IN PORTAL PRESSURE IN PATIENTS WITH CHRONIC HEPATITIS C-RELATED CIRRHOSIS

✍ Scribed by M. Garcia-Retortillo; D. Rincón; A. Albillos; J. Colmenero; R. Bataller; J.L. Calleja; R. Bañnares; J.G. Abraldes; J. Bosch; J.M. Sanchez-Tapias; X. Forns; J.C. Garcia-Pagán

• Book ID: 117378346
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 69 KB
• Volume: 52
• Category: Article
• ISSN: 0168-8278
• DOI: 10.1016/s0168-8278(10)60262-0